Brief: Biocept and Rosetta Genomics collaborate to evaluate microRNAs from circulating tumor cells
Oct 13 (Reuters) - Biocept Inc BIOC.O : * Biocept and Rosetta Genomics collaborate to evaluate microRNAs from circulating tumor cells * Companies will test for markers currently offered by Rosetta as well as pursue new potential markers * Source text for Eikon ID:nGNXVBTEBa * Further company coverage BIOC.O ((Bangalore Newsroom; +1 646 223 8780))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics